Literature DB >> 9700467

Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists.

H Matsubara1, M Inada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700467     DOI: 10.1507/endocrj.45.137

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


× No keyword cloud information.
  9 in total

Review 1.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

Review 2.  Mechanism of action of angiotensin-receptor blocking agents.

Authors:  H M Siragy; M Bedigian
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

3.  Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis.

Authors:  A Leri; F Fiordaliso; M Setoguchi; F Limana; N H Bishopric; J Kajstura; K Webster; P Anversa
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

4.  Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

Authors:  Y Tsutsumi; H Matsubara; H Masaki; H Kurihara; S Murasawa; S Takai; M Miyazaki; Y Nozawa; R Ozono; K Nakagawa; T Miwa; N Kawada; Y Mori; Y Shibasaki; Y Tanaka; S Fujiyama; Y Koyama; A Fujiyama; H Takahashi; T Iwasaka
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions.

Authors:  Jun Katada; Masataka Majima
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

6.  Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis.

Authors:  Yun-Wen Chen; Stella Tran; Isabelle Chenier; John S D Chan; Julie R Ingelfinger; Tadashi Inagami; Shao-Ling Zhang
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

7.  Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.

Authors:  Moon Young Kim; Soon Koo Baik; Dong Hun Park; Yoon Ok Jang; Ki Tae Suk; Chang Jin Yea; Il Young Lee; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Mi Yun Cho; Sang Baik Ko; Sei Jin Chang; Soon Ho Um; Kwang-Hyub Han
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

8.  Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells.

Authors:  Ping Lu; Hailin Liu; Hang Yin; Liu Yang
Journal:  Med Sci Monit       Date:  2011-09

9.  Angiotensinogen gene transcription in pulmonary fibrosis.

Authors:  Bruce D Uhal; My-Trang T Dang; Xiaopeng Li; Amal Abdul-Hafez
Journal:  Int J Pept       Date:  2012-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.